Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Pharmacy
Published in: International Journal of Clinical Pharmacy 6/2003

01-12-2003

Observational study of potential risk factors of medication administration errors

Authors: Edgar Tissot, Christian Cornette, Samuel Limat, Jean-Louis Mourand, Michèle Becker, Joseph-Philippe Etievent, Jean-Louis Dupond, Micheline Jacquet, Marie-Christine Woronoff-Lemsi

Published in: International Journal of Clinical Pharmacy | Issue 6/2003

Login to get access
Metadata
Title
Observational study of potential risk factors of medication administration errors
Authors
Edgar Tissot
Christian Cornette
Samuel Limat
Jean-Louis Mourand
Michèle Becker
Joseph-Philippe Etievent
Jean-Louis Dupond
Micheline Jacquet
Marie-Christine Woronoff-Lemsi
Publication date
01-12-2003
Publisher
Kluwer Academic Publishers
Published in
International Journal of Clinical Pharmacy / Issue 6/2003
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1023/B:PHAR.0000006519.44483.a0

Other articles of this Issue 6/2003

International Journal of Clinical Pharmacy 6/2003 Go to the issue

OriginalPaper

Frequency, nature and determinants of pharmacy compounded medicines in Dutch community pharmacies

OriginalPaper

Intravenous drug preparation practices: a survey in a French university hospital

OriginalPaper

"Death was a blessing" – should it ever be pharmaceutically hastened? British pharmacists' views

OriginalPaper

Investigator barriers and preferences to conduct clinical drug trials in Finland: a qualitative study

OriginalPaper

A qualitative approach to the use of economic data in the selection of medicines for hospital formularies: a French survey

OriginalPaper

Pharmacoeconomic research
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits